BusinessChina FDA Approves CTAs for BeyondSpring’s Second Global Plinabulin Registrational Trial for Chemotherapy-Induced Neutropenia PreventionBy Nasdaq OMXJul 6, 2017, 12:00 PM UTC
BusinessExosome Diagnostics Presents Breakthrough Liquid Biopsy Technologies at BIO International ConventionBy Nasdaq OMXJun 22, 2017, 3:55 PM UTC
BusinessCascadian Therapeutics to Present at Jefferies 2017 Healthcare ConferenceBy Nasdaq OMXMay 31, 2017, 12:30 PM UTC
BusinessIGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination TherapiesBy Nasdaq OMXMay 16, 2017, 1:58 PM UTC
BusinessIGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination TherapiesBy Nasdaq OMXMay 16, 2017, 1:58 PM UTC
BusinessBeyondSpring Chief Medical Officer to Present at Three Prominent Industry Conferences in May 2017By Nasdaq OMXMay 8, 2017, 12:31 PM UTC
BusinessBeyondSpring Chief Medical Officer to Present at Three Prominent Industry Conferences in May 2017By Nasdaq OMXMay 8, 2017, 12:31 PM UTC
BusinessBeyondSpring Enrolls First U.S. Patient in Phase 2/3 Clinical Trial of Plinabulin for Neutropenia PreventionBy Nasdaq OMXApr 25, 2017, 12:32 PM UTC
